Ono Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research and development of neuroscience, intracellular signaling, and genomic-based drugs. The company intends to acquire commercialization rights to new drug candidates in early…
Analysis
Bargain bin
Ono Pharmaceutical Co., Ltd. falls in the bargain bin: the price is low relative to peers, but the business metrics give reason to pause.
The price is attractive. You pay 9.6× its owner earnings: the cash an owner could take out each year, which is in the historically attractive zone. At today's price, the market is assuming roughly -4% yearly growth; analysts expect 47%. The price, in other words, assumes less than the experts do.
The trajectory is moderate and the balance sheet is sturdy. The company scores 16/20 on our value-creation score: strong value creator.
Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202375
81
2023202420252026
All-time high
81
Jun 2026
All-time low
55
Jan 2024
Average rank
69
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
30
69
41
39
Price/Earnings
60
88
100
89
Price/Book
75
88
62
61
Dividend Yield
91
91
89
77
Value (overall)
78
94
84
65
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.